Egf Theramed Health Stock Gross Profit

EVAHF Stock  USD 0.21  0.00  0.00%   
EGF Theramed Health fundamentals help investors to digest information that contributes to EGF Theramed's financial success or failures. It also enables traders to predict the movement of EGF Pink Sheet. The fundamental analysis module provides a way to measure EGF Theramed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EGF Theramed pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

EGF Theramed Health Company Gross Profit Analysis

EGF Theramed's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current EGF Theramed Gross Profit

    
  (105.22 K)  
Most of EGF Theramed's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EGF Theramed Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, EGF Theramed Health reported (105,225) of gross profit. This is 100.0% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The gross profit for all United States stocks is 100.0% higher than that of the company.

EGF Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EGF Theramed's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of EGF Theramed could also be used in its relative valuation, which is a method of valuing EGF Theramed by comparing valuation metrics of similar companies.
EGF Theramed is currently under evaluation in gross profit category among its peers.

EGF Fundamentals

About EGF Theramed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze EGF Theramed Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EGF Theramed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EGF Theramed Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in EGF Pink Sheet

EGF Theramed financial ratios help investors to determine whether EGF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EGF with respect to the benefits of owning EGF Theramed security.